Peer Reviewed
Feature Article Endocrinology and metabolism

Papillary thyroid cancer: the most common endocrine malignancy

James C Lee, Stanley B Sidhu
Abstract
Papillary thyroid cancer has an excellent prognosis and over 90% of affected patients achieve long-term survival. Treatment is primarily by surgery and postoperative radioactive iodine ablation, which may be required to be repeated in cases of recurrence.
Key Points
  • The main risk factors for papillary thyroid cancer are childhood radiation exposure and a family history.
  • A thorough history and examination, followed by appropriate investigations, are required when a patient presents with a neck lump suspected to be thyroid cancer.
  • The initial treatment of papillary thyroid cancer consists of surgery with or without postoperative radioactive iodine ablation.
  • During follow up, disease-free status is defined by: no clinical evidence of tumour; no evidence of tumour on imaging; and an undetectable serum thyroglobulin level.
  • As different specialists are involved at different stages of the management of thyroid cancer, the involvement of the GP from the initial diagnosis to the long-term follow up of the patient may provide a point of contact for the patient, a source of forgotten information, and a sense of continuity of care.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?